During the past decade, Ogikubo Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 8 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ogikubo Hospital" #1 sponsor was "Baxalta now part of Shire" with 2 trials, followed by "CSL Behring" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "LEO Pharma" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ogikubo Hospital" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator and "Guidant Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ogikubo Hospital" are "Hemophilia B" (3 trials), "Hemophilia A" (2 trials), "Arrhythmias, Cardiac" (1 trials), "Atopic Dermatitis" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Ogikubo Hospital" in a lesser frequency.

Most popular intervention types in "Ogikubo Hospital" are "Biological" (5 trials), "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Emicizumab" (2 trials), "Placebo" (2 trials), "rIX-FP" (2 trials), "BAX 326 (Recombinant factor IX)" (1 trials) and "Factor VIII (FVIII)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ogikubo Hospital" are 6 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Ogikubo Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ogikubo Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ogikubo Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".